Skip to content
Sunday, November 8, 2026
Openly Letter

The Zimbabwean Government Rejects ‘Lopsided’ American Healthcare Assistance Deal Because of Data Fears

Medical funding image
The offered US financial assistance was aimed at programmes for HIV/Aids treatment and prevention, TB, and malarial diseases.

The nation of Zimbabwe has turned down a significant US health deal valued at 367 million US dollars (£272m) over five years due to the United States' demand for sensitive biological samples.

This rejection came to light following a internal memorandum dated December was leaked, revealing that Head of State Emmerson Mnangagwa felt the agreement was "lopsided".

A government spokesperson has since stated that the United States was demanding access to biological samples for scientific study and commercial gain but was unwilling to guarantee the benefits from future treatments.

"We must now begin the difficult and regrettable task of ending our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.

Her embassy said the US had furnished over $1.9bn in health funding to Zimbabwe over the last twenty years.

A doctors' association in Zimbabwe has called for further talks to secure a agreement agreeable to both sides so the nation's critical HIV programme can continue.

Wider Background

Zimbabwe's decision comes after a comparable situation in Kenya, where a high court blocked a similar health funding agreement following legal challenges were filed about the security of Kenyans' medical information.

After returning to office recently, US President Donald Trump has drastically cut foreign aid and closed the key foreign aid agency.

The agency had administered aid for the US government, but Trump stated its expenditure was "inefficient" and his administration was pursuing government-to-government agreements to boost openness and responsibility.

According to statements, Sixteen African countries have so far signed similar agreements, constituting more than $18.3bn of fresh investment.

Specifics of the Rejected Deal

The funds for Zimbabwe was intended to gone towards "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"We are confident this cooperation might have yielded immense benefits for Zimbabwean communities, especially the 1.2 million men, women and children currently receiving HIV treatment via US-supported initiatives," the Ambassador commented.

However, government spokesperson Nick Mangwana argued the proposed deal was "unequal".

"Zimbabwe was being asked to surrender its genetic material and health information indefinitely, without any equivalent promise of benefiting from any scientific breakthroughs – such as new medicines or tests – that might result from that provided information," Mangwana explained.

"Effectively, our nation would provide the basic resources for medical research without any certainty that the resulting innovations would be accessible to our citizens if a future pandemic arise."

National Interest and Global Health

He also pointed out that the American exit from the global health body and its push of bilateral deals were undermining systems previously established through the international organization.

The spokesperson gave as an example its Pandemic Benefit-Sharing scheme designed to deal with potential global health emergencies.

"This system is designed to guarantee that when a country provides its samples, the resulting advantages – including vaccines and treatments – are shared equitably, not commercialised solely by those with the capability to develop them."

The government's concerns regarding the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.

"We encourage ongoing dialogue with our US partners on how future co-operation might be designed in a way that honours the sovereignty and dignity of both nations."

Medical Community Response

The Zimbabwe College of Public Health Physicians (ZCPHP) said it acknowledged the government's concerns, but urged that talks should continue given that a large portion of the nation's HIV programmes relied on external financing.

"Where specific concerns arise, including those involving data governance or agreement terms, these can frequently be resolved through detailed discussion and mutually agreed protections," it said.

The situation highlights the continuing debate between receiving much-needed foreign assistance and safeguarding local interests in an increasingly data-driven world.

The writer

Tracy Bishop

A freelance writer and community advocate who explores social issues and personal growth through storytelling.

Openly Letter

Type to search articles.